Listed by the USPTO as JAVANMARD, SAHAR
Tech Center 1600 • Art Units: 1617 1622 1627
This examiner grants 65% of resolved cases
JAVANMARD, SAHAR is a USPTO patent examiner in Tech Center 1600 and Art Unit 1617. The profile includes 756 resolved cases, an allowance rate of 65.1%, and a median of 1045 days to allowance. The interview lift is 34.0%, making interviews a meaningful consideration when planning responses and claim discussions.
The leading companies are Intra-cellular Therapies Inc., Verastem Inc., and Prilenia Neurotherapeutics Ltd. The listed firms are GOODWIN PROCTER LLP, COOLEY LLP, and HOXIE & ASSOCIATES LLC. These organizations give practitioners useful reference points for reviewing prosecution approaches in the relevant life sciences activity.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18773675 | OINTMENT CONTAINING AN OXAZOLE COMPOUND | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18506916 | aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18722917 | CRYSTAL OF SUBSTITUTED PIPERIDINE COMPOUND, SALTS OF SUBSTITUTED PIPERIDINE COMPOUND, AND CRYSTALS THEREOF | Non-Final OA | Eisai R&D Management Co., Ltd. |
| 18719710 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Non-Final OA | ILDONG PHARMACEUTICAL CO., LTD. |
| 18411512 | THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES | Non-Final OA | INTRABIO LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy65.1% of resolved applications examined by Sahar Javanmard were allowed (756 resolved cases), compared with 34.2% across Art Unit 1617 over the last five years.
This examiner's interview lift is +34.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sahar Javanmard took 1,045 days on average from filing to allowance.
Sahar Javanmard examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).